PFW Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.16M Sell
12,424
-680
-5% -$158K 0.92% 20
2026
Q1
$3.2M Sell
13,104
-174
-1% -$40.5K 1.01% 17
2025
Q4
$2.75M Sell
13,278
-598
-4% -$118K 0.83% 22
2025
Q3
$2.57M Sell
13,876
-56
-0.4% -$9.59K 0.76% 29
2025
Q2
$2.13M Sell
13,932
-639
-4% -$98.2K 0.65% 37
2025
Q1
$2.42M Buy
14,571
+98
+0.7% +$15.3K 0.76% 31
2024
Q4
$2.09M Buy
+14,473
New +$2.24M 0.64% 38
2024
Q2
$2.09M Buy
14,304
+336
+2% +$50K 0.67% 36
2024
Q1
$2.21M Sell
13,968
-269
-2% -$42.8K 0.68% 36
2023
Q4
$2.23M Buy
14,237
+493
+4% +$75.6K 0.71% 31
2023
Q3
$2.14M Buy
13,744
+614
+5% +$101K 0.76% 25
2023
Q2
$2.28M Buy
+13,130
New +$2.12M 0.76% 25
2019
Q3
$2.31M Buy
+14,235
New +$1.88M 0.7% 34

Other funds holding JNJ

PFW Advisors's JNJ Position: Q2 2026 in Review

PFW Advisors reduced its Johnson & Johnson (JNJ) stake by 5.2% in Q2 2026, selling an estimated $158K and leaving 12,424 shares worth $3.16M. The position accounts for 0.92% of the portfolio, ranked #20.

PFW Advisors first reported a position in JNJ in Q3 2019 and has held it in 13 quarters since. The position peaked at $3.2M in Q1 2026. 1,021 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • PFW Advisors held 12,424 shares of Johnson & Johnson worth $3.16M as of Q2 2026.
  • PFW Advisors sold 680 Johnson & Johnson shares in Q2 2026, an estimated $158K.
  • Johnson & Johnson made up 0.92% of PFW Advisors's portfolio in Q2 2026, its #20 holding.
  • PFW Advisors first reported a position in Johnson & Johnson in Q3 2019 and has held it in 13 quarters since.
  • PFW Advisors's Johnson & Johnson position peaked at $3.2M in Q1 2026.
  • 1,021 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on PFW Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.